Literature DB >> 6594927

Phase II evaluation of aclacinomycin-A (NSC-208734) in adenocarcinoma of the kidney.

D A Decker, A Drelichman, M I Opipari, M Al-Sarraf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6594927     DOI: 10.1097/00000421-198410000-00026

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


× No keyword cloud information.
  1 in total

1.  A phase II trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neck.

Authors:  J L Eckenrode; R H Wheeler; A A Forastiere
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.